Adamas Pharmaceuticals, Inc.
USD8.22
+0.00 (+0.00%)
CEO
Neil McFarlane
IPO Date
2014-04-10
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Country
US
Open
$8.24
Prev. Close
$8.22
Day Low
$8.18
Day High
$8.25
52W Low
$4.02
52W High
$9.15
Volume
3.15M
| -1.0 |
| 31 Dec 2018 | FY | 98.1% | -384.8% | -145.7% | -55.8% | 1.33 | 9.41 | -1.8 |
| 31 Dec 2017 | FY | 97.0% | -15672.5% | -135.3% | -48.1% | 1.55 | 10.79 | -8.5 |
| 31 Dec 2016 | FY | 100.0% | -10499.7% | -45.4% | -42.2% | 0.00 | 12.01 | -6.1 |
| 31 Dec 2015 | FY | 100.0% | -2703.7% | -44.6% | -40.2% | 0.00 | 9.59 | -9.9 |
| 31 Dec 2014 | FY | 100.0% | 18.3% | 7.0% | 6.3% | 0.00 | 9.85 | 25.2 |
| 31 Dec 2013 | FY | 100.0% | 71.6% | 62.1% | 59.1% | 0.00 | 20.39 | 3.7 |
| 31 Dec 2012 | FY | 100.0% | 47.3% | 357.0% | 27.6% | 0.81 | 1.67 | 7.5 |
| -4.9 |
| 31 Mar 2021 | Q1 | 98.0% | -65.1% | -211.8% | -7.4% | 22.86 | 5.42 | -3.4 |
| 31 Dec 2020 | Q4 | 97.2% | -87.0% | 36.6% | -15.2% | -2.60 | 3.20 | -1.7 |
| 30 Sept 2020 | Q3 | 97.6% | -59.1% | 34.4% | -9.0% | -3.75 | 3.94 | -2.5 |
| 30 Jun 2020 | Q2 | 98.0% | -56.2% | 43.3% | -7.9% | -5.31 | 5.83 | -1.7 |
| 31 Mar 2020 | Q1 | 96.0% | -115.0% | 105.0% | -11.5% | -8.16 | 5.61 | -1.2 |
| 31 Dec 2019 | Q4 | 97.3% | -141.1% | 2584.0% | -14.2% | -143.02 | 5.58 | -1.1 |
| 30 Sept 2019 | Q3 | 93.3% | -198.0% | -139.6% | -15.3% | 6.37 | 6.35 | -1.3 |
| 30 Jun 2019 | Q2 | 94.6% | -196.0% | -58.2% | -12.4% | 2.89 | 7.27 | -1.7 |